Nycomed US Plans Growth Through Acquisition
This article was originally published in The Pink Sheet Daily
Executive SummaryNow that Takeda has entered into a $13 billion deal to buy Nycomed, the U.S. affiliate, which isn't part of the deal, plans to grow sales by 10% annually through 2015.
You may also be interested in...
Takeda is to close two R&D facilities in Germany and to cut commercial activities in the U.S., as it looks for cost savings from the 2011 acquisition of Nycomed.